Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Net-Receivables" stands at 353.85 Billion Japanese Yens as of 09/30/2025, the highest value since 06/30/2023.
As of the end of Chugai Pharmaceutical Co. Ltd.'s third quarter, the item "Net Receivables" stands at 353.85 Billion JPY. This represents an increase of 11.64 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.93 percent compared to the value the year prior.
The 1 year change in percent is 7.93.
The 3 year change in percent is 28.48.
The 5 year change in percent is 57.75.
The 10 year change in percent is 155.43.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Receivables | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Receivables | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Receivables | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Receivables | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Receivables | 280,205,508,085.11 |